Skip to content

Achaogen, Inc.

Delisted

CIK 1301501fmd_1020GJDGGJ5TJ7J2P83GC3G3YQManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2012 to Dec 31, 2018, 25 periods

Latest annual · FY2018

Millions
Total revenues
9
Gross profit
9
Operating income
(189)
Net income
(187)
Free cash flow
(174)

Latest quarter · Q4 FY2018

Millions
Total revenues
2
Gross profit
2
Operating income
(44)
Net income
(48)
Free cash flow
(32)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2015 to FY2018
-30.6%
Revenue, 5 yearsFY2013 to FY2018
n/m
Net income, 5 yearsFY2013 to FY2018
n/m

Achaogen, Inc. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2018FY2017ChangeSource
Revenue$8.7 million$11.2 million-21.9%10-K 2019-04-01 · proof
Gross profit$8.7 million10-K 2019-04-01 · proof
Operating income-$189.2 million-$126.3 million10-K 2019-04-01 · proof
Net income-$186.5 million-$125.6 million10-K 2019-04-01 · proof
Cash from operating activities-$165 million-$95.3 million10-K 2019-04-01 · proof
Free cash flow-$174 million-$102.4 million10-K 2019-04-01 · proof
Total assets$82.3 million$197.1 million-58.2%10-K 2019-04-01 · proof
Total liabilities$88.6 million$65.1 million+36%10-K 2019-04-01 · proof
Cash and cash equivalents$31 million$145.2 million-78.7%10-K 2019-04-01 · proof
What was Achaogen, Inc.'s revenue in fiscal 2018?
Achaogen, Inc. reported revenue of $8.7 million for fiscal 2018 (the year ended Dec 31, 2018), against $11.2 million the year before (-21.9%). Source: the 10-K filed with the SEC on Apr 1, 2019. SEC
What was Achaogen, Inc.'s gross profit in fiscal 2018?
Achaogen, Inc. reported gross profit of $8.7 million for fiscal 2018 (the year ended Dec 31, 2018). Source: the 10-K filed with the SEC on Apr 1, 2019. SEC
What was Achaogen, Inc.'s operating income in fiscal 2018?
Achaogen, Inc. reported operating income of -$189.2 million for fiscal 2018 (the year ended Dec 31, 2018), against -$126.3 million the year before. Source: the 10-K filed with the SEC on Apr 1, 2019. SEC
What was Achaogen, Inc.'s net income in fiscal 2018?
Achaogen, Inc. reported net income of -$186.5 million for fiscal 2018 (the year ended Dec 31, 2018), against -$125.6 million the year before. Source: the 10-K filed with the SEC on Apr 1, 2019. SEC
What was Achaogen, Inc.'s cash from operating activities in fiscal 2018?
Achaogen, Inc. reported cash from operating activities of -$165 million for fiscal 2018 (the year ended Dec 31, 2018), against -$95.3 million the year before. Source: the 10-K filed with the SEC on Apr 1, 2019. SEC
What was Achaogen, Inc.'s free cash flow in fiscal 2018?
Achaogen, Inc. reported free cash flow of -$174 million for fiscal 2018 (the year ended Dec 31, 2018), against -$102.4 million the year before. Source: the 10-K filed with the SEC on Apr 1, 2019. SEC
What are Achaogen, Inc.'s total assets?
As of Dec 31, 2018, Achaogen, Inc. reported total assets of $82.3 million, against $197.1 million a year earlier (-58.2%). Source: the 10-K filed with the SEC on Apr 1, 2019. SEC
What are Achaogen, Inc.'s total liabilities?
As of Dec 31, 2018, Achaogen, Inc. reported total liabilities of $88.6 million, against $65.1 million a year earlier (+36%). Source: the 10-K filed with the SEC on Apr 1, 2019. SEC
What are Achaogen, Inc.'s cash and cash equivalents?
As of Dec 31, 2018, Achaogen, Inc. reported cash and cash equivalents of $31 million, against $145.2 million a year earlier (-78.7%). Source: the 10-K filed with the SEC on Apr 1, 2019. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1301501&period_type=annual&limit=5"

Information only, not investment advice.